These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34785213)

  • 21. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
    Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
    Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
    Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
    J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
    Li Y; Wang Z; Kong D; Li R; Sarkar SH; Sarkar FH
    J Biol Chem; 2008 Oct; 283(41):27707-27716. PubMed ID: 18687691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
    Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
    Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.
    Ko S; Shi L; Kim S; Song CS; Chatterjee B
    Mol Endocrinol; 2008 Feb; 22(2):273-86. PubMed ID: 17975021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
    Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH
    Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative analysis of AR-mediated transcriptional regulatory network reveals IRF1 as an inhibitor of prostate cancer progression.
    Cheng Y; Wang D; Jiang J; Huang W; Li D; Luo J; Gu W; Mo W; Wang C; Li Y; Gu S; Xu Y
    Prostate; 2020 May; 80(8):640-652. PubMed ID: 32282098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen Receptor Upregulates Mucosa-Associated Lymphoid Tissue 1 to Induce NF-κB Activity via Androgen-Dependent and -Independent Pathways in Prostate Carcinoma Cells.
    Chang KS; Chen ST; Sung HC; Hsu SY; Lin WY; Hou CP; Lin YH; Feng TH; Tsui KH; Juang HH
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel lncRNA
    Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
    Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.
    Dixon KM; Lui GY; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR
    Br J Cancer; 2013 Feb; 108(2):409-19. PubMed ID: 23287991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1).
    Xi R; Pun IH; Menezes SV; Fouani L; Kalinowski DS; Huang ML; Zhang X; Richardson DR; Kovacevic Z
    Mol Pharmacol; 2017 May; 91(5):499-517. PubMed ID: 28275050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.
    Ferreira LB; Palumbo A; de Mello KD; Sternberg C; Caetano MS; de Oliveira FL; Neves AF; Nasciutti LE; Goulart LR; Gimba ER
    BMC Cancer; 2012 Nov; 12():507. PubMed ID: 23130941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis.
    Lin HP; Ho HM; Chang CW; Yeh SD; Su YW; Tan TH; Lin WJ
    FASEB J; 2019 Dec; 33(12):14653-14667. PubMed ID: 31693867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
    Sarwar M; Sandberg S; Abrahamsson PA; Persson JL
    Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
    Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1.
    Park KC; Menezes SV; Kalinowski DS; Sahni S; Jansson PJ; Kovacevic Z; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2644-2663. PubMed ID: 29679718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogen sulfide represses androgen receptor transactivation by targeting at the second zinc finger module.
    Zhao K; Li S; Wu L; Lai C; Yang G
    J Biol Chem; 2014 Jul; 289(30):20824-35. PubMed ID: 24942741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.